BioCentury
ARTICLE | Clinical News

Leukine GM-CSF data

May 16, 1994 7:00 AM UTC

The Seattle company reported that the cytokine at doses of 125 µg/m2/day was administered safely as a prophylaxis against infection in 10 high-risk cancer surgery patients.

Patients received drug for 10 days, beginning five days prior to surgery, and were followed for 30 days after surgery. Enrollment criteria were high risk surgery, operations of greater than four hours' duration, and comorbid conditions such as diabetes and malnutrition. ...